VIDEO: Blinatumomab, inotuzumab reshape relapsed ALL treatmentApril 9, 2017ImmunotherapyLeukemia, Myelodysplasia, Transplantation
Atezolizumab improved survival in triple-negative breast cancerApril 8, 2017Breast CancerImmunotherapy
Get ready for cancer immunotherapy-induced rheumatic diseasesApril 3, 2017ImmunotherapyMelanomaImmuno-oncology
Peptide vaccine shows early promise in ovarian, endometrial cancersMarch 25, 2017Gynecologic CancerImmunotherapy
Connective tissue diseases reported in patients receiving immune checkpoint inhibitorsMarch 3, 2017Patient & Survivor CareImmunotherapyMelanomaImmuno-oncology
Nivolumab shows promise for pretreated advanced HCCFebruary 3, 2017GastroenterologyImmunotherapyGastrointestinal Cancer
Nivolumab safe, effective for salvage in advanced gastric cancerJanuary 21, 2017GastroenterologyImmunotherapyRare DiseasesGastrointestinal Cancer
VIDEO: Improved QOL an added benefit of pembrolizumab for NSCLC patientsDecember 14, 2016Lung CancerPatient & Survivor CareImmunotherapy
Vaccine/PD-1 inhibitor combo shows early promise against mCRPCNovember 29, 2016Genitourinary CancerImmunotherapy
